No Data
No Data
Tharimmune Signs Nonbinding LOI to Merge With Intract Pharma
Express News | Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma
Tharimmune Partners With Intract Pharma to Develop Oral Version of Infliximab for Autoimmune Diseases
Express News | Tharimmune Acquires Global License & Partners With Intract Pharma to Develop Oral Formulation of Infliximab
Tharimmune | 10-Q: Q2 2024 Earnings Report
Tharimmune Appoints Global Business Executive David H. Clarke as Key Strategic Advisor
No Data
No Data
EUGENE啊梁 : Not taking off.
Trytosaveabit OP EUGENE啊梁 : Only PM! So hard to trade! Only a fraction of traders are/can trade!